Klinische Wochenschrift

, Volume 67, Issue 8, pp 456–462 | Cite as

Plasma-Katecholamin-Verlauf bei Alkylphosphat-Intoxikationen und deren Therapie

  • G. Kauert
  • B. Schoppek
  • M. v. Clarmann
  • A. Hibler
Kasuistiken

Abkürzungsverzeichnis

Amp.

Ampulle

ChE

Cholinesterase

HPLC

High pressure liquid chromatography (Hochdruckflüssig-Chromatographie)

Li

Lithium

m-Rezeptoren

muskarinische Rezeptoren

n-Rezeptoren

nikotinische Rezeptoren

®

eingetragenes Warenzeichen

ZVD

Zentraler Venendruck

Plasma catecholamine kinetics in the course of organophosphate-poisonings and their therapy

Summary

In connection with the “endogenous acetylcholine-poisoning” due to organophosphorous compounds beside the clinical important muscarinic and nicotinic symptoms an activation of the sympathetic nervous system (adrenal medulla, sympathetic ganglia) is expected. Therefore a kinetic profile of norepinephrine and epinephrine in the plasma of two patients with severe parathionpoisonings was taken up through the whole period of the intensive-medical treatment. The method used was HPLC with electrochemical detection. The parathion-concentration of the same plasma samples were measured, too. The result were individual different courses with periodically appearing, markedly increased plasma catecholamine values. A direct correlation of catecholamines with the parathion-concentration was not recognizable. A possible influence of the atropine-treatment as well as of stress-factors is discussed but estimated as not responsible for the observed peaks.

Key words

Plasma catecholamines Norepinephrine Epinephrine Organophosphate poisoning 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aigner H, McManus J (1985) Bestimmung der Katecholamine mit neuem Detektor und Chemikalien-Kit. Labor-Medizin 8:110–112Google Scholar
  2. 2.
    Akerstedt T, Gillberg M, Hjemdahl P, Sigurdson K, Gustavsson I, Daleskog M, Pollare T (1983) Comparison of uronary and plasma catecholamine responses to mental stress. Acta Physiol Scand 117:19–26Google Scholar
  3. 3.
    Baselt RC (1982) Disposition of toxic drugs and chemicals in man. Biochemical Publications, Davis, California, pp 596–599Google Scholar
  4. 4.
    Boelke G, Butigan N, Davar H, Erdmann WD, Gaaz JW, Nenner M (1970) Neue Erfahrungen bei der toxikologisch kontrollierten Therapie einer ungewöhnlich schweren Vergiftung mit Nitrostigmin (E 605 forte®). Dtsch Med Wochenschr 95:2516–2520Google Scholar
  5. 5.
    Frankenhäuser M et al. (1967) Physiological, behaviourial and subjective indices of activation in habituation experiments. Physiol Behav 2:229–237Google Scholar
  6. 6.
    Frankenhäuser M et al. (1970) Effect of punishment on catecholamine release and efficiency of performance. Psychopharmacologica 17:378–390Google Scholar
  7. 7.
    Frankenhäuser M (1971) Behaviour and circulating catecholamines. Brain Res 31:241–262Google Scholar
  8. 8.
    Kampschulte R, Hornung E, Liebold I (1982) Trendunter-suchung der suicidalen Intoxikationen. Intensivmedizin 19(6):259–263Google Scholar
  9. 9.
    Knedel M, Böttger R (1967) Eine kinetische Methode zur Bestimmung der Aktivität der Pseudocholinesterase (Acylcholin-acylhydrolase 3.1.1.8) Klin Wochenschr 45:325–327Google Scholar
  10. 10.
    Langer SZ (1981) Presynaptic regulation of the release of catecholamines. Pharm Rev 32/4:337–362Google Scholar
  11. 11.
    Marosi G, Ivan J, Nagymaytenyi L, Toszegi A (1985) Dimethoate-induced toxic cardiac failure in the guinea pig. Arch Tox 57:142–143Google Scholar
  12. 12.
    Okonek S (1975) Akiuelle Gesichtspunkte zur Intoxikation durch Alkylphosphate — Biochemische Befunde, Symptomatik und Therapie. Internist 16(3):123–130Google Scholar
  13. 13.
    Okonek S (1978) Alkylphosphat-Intoxikationen. Arbeitsmed Soz Med Präv med 13:243–247Google Scholar
  14. 14.
    Okonek S, Kilbinger H, Schuster CJ, Bierbach H, Muth A (1979) Phäochromocytom-ähnliche Katecholaminausscheidung im Urin von Patienten mit Alkylphosphat-Intoxikationen. Verh Dt Ges Inn Med 85:1321–1324Google Scholar
  15. 15.
    Patel S (1981) Regulation of catecholamine release by presynaptic-receptor system. Gen Pharmacol 12(6):405–422Google Scholar
  16. 16.
    Patkai P (1970) Catecholamine excretion in pleasant and unpleasant situations. Rep Psychol Lab Univ Stockholm 294:341–346Google Scholar
  17. 17.
    Rote Liste 1988 (Hrsg.: Bundesverband der Pharmazeutischen Industrie e.V. Frankfurt/Main 1988)Google Scholar
  18. 18.
    Wirth W, Gloxhuber Ch (1985) Toxikologie, 4. Aufl, Thieme, Stuttgart New YorkGoogle Scholar
  19. 19.
    Wren C, Carson PHM, Sanderson JM (1981) Organophosphate poisoning and complete heart block. J Roy Soc Med 74:688–689Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • G. Kauert
    • 1
  • B. Schoppek
    • 1
  • M. v. Clarmann
    • 2
  • A. Hibler
    • 2
  1. 1.Institut für Rechtsmedizin der Universität MünchenGermany
  2. 2.Toxikologische Abteilung des Klinikums rechts der Isar der Technischen Universität MünchenGermany

Personalised recommendations